Articles by Disease (Ventricular Dysfunction )

Isolated Natural Antioxidants as a new Possible Therapeutic Alternative for the Treatment of Hypertension

Journal: Current Hypertension Reviews
Volume: 19
Page: 7-18
Author(s): Matheus Vinicius Barbosa da Silva, Maria Alessandra da Silva Lima, Lizandra Henrique de Farias, Vanessa Maria dos Santos and Thyago Moreira de Queiroz*

Hemodynamic Changes after Continuing or Omitting Regular Angiotensin Converting Enzyme Inhibitors before Cataract Surgery: A Comparative Study

Journal: Current Hypertension Reviews
Volume: 19
Page: 59-65
Author(s): Saeed Khademi, Reza Jouybar, Sedigheh Ahmadi*, Naeimehossadat Asmarian, Maryam Ghadimi, Mehrdad Salari and Soodabeh Emami

The Effect of Bisoprolol on Premature Ventricular Complex in Vietnamese Patients with Hypertension and Left Ventricular Hypertrophy

Journal: Current Hypertension Reviews
Volume: 19
Page: 42-51
Author(s): Son Kim Tran, Toan Hoang Ngo*, Anh Thi Phuong Nguyen, Huyen Thi Ngoc Huynh, Cuong Tan Vo, Ngan Ngoc Bao Nguyen, Thang Hoang Nguyen and Minh Van Huynh

Regulatory Mechanisms of Vanillic Acid in Cardiovascular Diseases: A Review

Journal: Current Medicinal Chemistry
Volume: 30
Page: 2562-2576
Author(s): Naser-Aldin Lashgari, Nazanin M. Roudsari, Saeideh Momtaz*, Amir H. Abdolghaffari*, Stephen L. Atkin* and Amirhossein Sahebkar*

HDAC3 Impairs Cardiac Function in Chronic Heart Failure Rats via Mediating MicroRNA-26b-3p to Target High Mobility Group AT-Hook 2

Journal: Current Medicinal Chemistry
Volume: 30
Page: 2577-2589
Author(s): Xinyuan Han, Shunda Wang, Zhijun Yong, Xueting Zhang, Xuanqi Wang and Chaofeng Sun*

Effects of Exercise on Vascular Toxicity Associated with Breast Cancer Treatment: A Narrative Review

Journal: Current Vascular Pharmacology
Volume: 21
Page: 42-50
Author(s): Marina L.D. Pera and Guilherme F. Speretta*

Dose-dependent Effects of PRC2 and HDAC Inhibitors on Cardiomyocyte Hypertrophy Induced by Phenylephrine

Journal: Current Drug Targets
Volume: 24
Page: 371-378
Author(s): Zhenyi Zhao, Jian Lv, Ningning Guo, Qiuxiao Guo, Sai Zeng, Yu Fang, Weixin Chen* and Zhihua Wang*

The Emerging Role of Sodium-glucose Cotransporter 2 Inhibitors in Heart Failure

Journal: Current Pharmaceutical Design
Volume: 29
Page: 481-493
Author(s): Mauro Gitto, Alessandro Villaschi, Massimo Federici, Gianluigi Condorelli and Giulio G. Stefanini*

Advances in the Management of Heart Failure with Reduced Ejection Fraction; The Role of SGLT2is, ARNI, Myotropes, Vericiguat, and Anti-inflammatory Agents: A Mini-review

Journal: Current Pharmaceutical Design
Volume: 29
Page: 509-518
Author(s): Dimitrios A. Vrachatis*, Konstantinos A. Papathanasiou, Sotiria G. Giotaki, Konstantinos Raisakis, Andreas Kaoukis, Charalampos Kossyvakis, Andreas Theodorakis, Stauros Pediotidis, Dimitrios Avramides, Gerasimos Siasos and Spyridon Deftereos

The Role of Exercise-based Cardiac Rehabilitation in Heart Failure

Journal: Current Pharmaceutical Design
Volume: 29
Page: 494-501
Author(s): Jeanne Shan Yin Ong, Weiqin Lin and Tee Joo Yeo*